Electrostatic complementarity of B-cell receptor CDR3s and TP53-mutant amino acids in breast cancer is associated with increased disease-free survival rates.
Juan F ArturoBoris I ChobrutskiyMichelle YeagleyDhruv N PatelShayan FalasiriJay S PatelGeorge BlanckPublished in: Cellular & molecular immunology (2019)